Orforglipron, marketed as Foundayo, has been authorised for use by the Medicines and Healthcare products Regulatory Agency (MHRA). The approval comes after the MHRA authorised the first GLP-1 pill for weight loss, an oral form of Wegovy, in June. He said: "Firstly, this medication is being authorised for people at lower body weights than other weight loss medications. "Pill medications are much cheaper to manufacture than injectable medications, and the nature of the active compound in this medication is much cheaper to make than those found in injectable medications or in oral Wegovy." "Having another oral treatment option expands choice, particularly for individuals who are reluctant to use injectable medicines or who may not require the degree of weight loss typically achieved with the most effective injections.